RGEN

Conviction 76HealthcareScan · Thu, Jun 25, 2026

RGEN$145.38+5.04%

ResistanceSupportVol 14Insider sellCongress buyCongress sell

Vol MA14 1.07M

Mar 26Apr 14May 1May 19Jun 8Jun 25

REPLIGEN CORPBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.repligen.com ↗

Price145.38

Change+5.04%

Gap+3.32%

Rel volume1.92×

Avg volume1.04M

Avg $ vol135.7M

SMA 20128.82

SMA 50122.31

SMA 200138.47

Price vs 50+18.87%

Price vs 200+4.99%

MA stackmixed

50/200 cross—

Supertrendup · 123.92

RSI (14)70

MACD hist1.08

MACD crossbull · 1d

Stoch %K / %D88 / 75

ADX (14)25

+DI / −DI34 / 12

RSI divergence—

MACD divergence—

ATR %+4.71%

ADR %4.91%

52w high172.26

52w low102.87

From 52w high-15.60%

Above 52w low+41.32%

New 52w highNo

SqueezeOff

Bollinger width18.55%

%B1.19

Donchian pos90.50%

Donchian high148.78

Donchian low113.04

AVWAP (52w high)127.69

vs AVWAP high+13.86%

AVWAP (52w low)121.40

vs AVWAP low+19.75%

OBV trendUp

Chaikin MF (20)0.08

Today vs 20d1.92×

Avg vol (14d)1.07M

Avg vol (20d)1.04M

Avg $ vol (20d)135.7M

Market cap8.2B

RS 3m (vs SPY)+6.75%

RS 6m (vs SPY)-22.50%

RS line new highYes

Trend template6/8

Technical rank62.3

1 week+8.86%

1 month+26.21%

3 months+27.17%

6 months-12.20%

1 year+17.86%

YTD-11.54%

P/E167.72

P/B3.89

P/S58.06

P/FCF87.33

EPS0.8600

Div yield—

ROE2.32%

ROA1.67%

Debt/Eq0.26

Current9.20

EV/EBITDA60.97

Gross margin42.83%

Net margin34.62%

Rev growth35.10%

EPS growth291.64%

Price target161.27

Target upside10.93%

Analyst ratingBuy

Institutional126.81%

Ent. value8.16B

Revenue44.83M

Net income8.33M

Gross profit—

Free cash flow93.9M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out56.41M

Employees2K

ListedTue, Apr 29, 1986

Free float55.93M

Float %99.2%

Short interest5.96M

Days to cover4.9d

Short volume46.2%

Squeeze score64 / 100

Next earningsTue, Aug 4, 2026 (40d)

EPS forecast$0.46 · 5 est

Last EPS vs est$0.48 vs $0.38

Last surprise+26.3% beat

Setup gradeA

Conviction76 / 100

Pattern quality—

Tech rank62.3 / 100

Group rank50 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance136.13

Support106.50

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 17 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

Setting up
Jun 9 – Jun 10
2 scans
→
Breaking out now
Jun 11
1 scan
→
Setting up
Jun 12 – Jun 15
2 scans
→
Breaking out now
Jun 16
1 scan

Congress activity

Disclosed STOCK Act trades in RGEN · 6 recent

All disclosures →

Member	Side	Amount	Traded	Filed	PTR
Lisa McClain house · MI · traded 2025-10-30	Sell	$1K–$15K	2025-10-30	2025-11-01	PDF
Lisa McClain house · MI · traded 2025-10-31	Sell	$1K–$15K	2025-10-31	2025-11-01	PDF
Lisa McClain house · R · MI · traded 2025-06-17	Sell	$1K–$15K	2025-06-17	2025-08-13	PDF
Lisa McClain house · R · MI · traded 2025-07-22	Buy	$1K–$15K	2025-07-22	2025-08-13	PDF
Lisa McClain house · R · MI · traded 2025-06-11	Buy	$1K–$15K	2025-06-11	2025-08-13	PDF
Jefferson Shreve house · R · IN · traded 2025-04-07	Sell	$15K–$50K	2025-04-07	2025-05-08	PDF

Insider activity

SEC Form 4 transactions in RGEN · 10 buys

Insider	Side	Shares	Value	Traded	Filed
Konstantinov Konstantin Director · Stock Option (Right to Buy) · 2026-05-14	Grant	2.24K	$0	2026-05-14	2026-05-18
DAWES KAREN A Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
Konstantinov Konstantin Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
Mhatre Rohin Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
Pax Margaret Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
EGLINTON MANNER CARRIE Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
BARTHELEMY NICOLAS Director · Common Stock · 2026-05-14	Grant	995	$0	2026-05-14	2026-05-18
Madaus Martin D Director · Stock Option (Right to Buy) · 2026-05-14	Grant	2.24K	$0	2026-05-14	2026-05-18
Pax Margaret Director · Stock Option (Right to Buy) · 2026-05-14	Grant	2.24K	$0	2026-05-14	2026-05-18
BARTHELEMY NICOLAS Director · Stock Option (Right to Buy) · 2026-05-14	Grant	2.24K	$0	2026-05-14	2026-05-18

SEC filings

EDGAR filings in RGEN · 1 recent

EDGAR →

144144Thu, Jun 25, 2026

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.